Huntsman Cancer Institute (HCI) has a robust and highly interactive Senior Leadership team comprised of eight individuals: HCI Executive Director: Mary Beckede, PhD Senior Director of Finance and Administration: Scott Lloyd, MBA, CPA Senior Director of Basic Science: Barbara Graves, PhD Senior Director of Early Translational Research: David Jones, PhD Senior Director of Clinical Research: Sunil Sharma, MD Senior Director of Community Oncology Research: Wallace Akerley, MD Senior Director of Prevention and Outreach: Randall Burt, MD Senior Director of Clinical Affairs: Sean Mulvihill, MD Huntsman Cancer Hospital (HCH) Executive Director: Ray Lynch, MBA, CPA The Senior Leadership is responsible for strategic planning, integration, financial management, and evaluation of all three areas of the HCI mission: research, clinical care, and education/outreach. In the research arena, members of the Senior Leadership oversee CCSG Programs, Shared Resources, and Support Services such as the Protocol Review and Monitoring System. They also provide leadership regarding data and safety monitoring as well as participation of minorities and children in clinical trials. HCI Senior Leadership forms the Director's Cabinet. The Cabinet meets weekly for one to two hours with an agenda and holds a two-to-three day off-site retreat in the winter each year, as well as a multi-day spring conference to review and finalize the next year's budget. In addition, each Senior Leader meets individually with Dr. Beckerle on a regulady scheduled weekly, bi-weekly, or monthly (minimum level) calendar, depending on particular needs. The Executive Director and Senior Directors of Finance and Administration, Basic Science, Eady Translational Research, Clinical Research, Community Oncology Research, and Prevention and Outreach are members of the Research Leadership Council, which leads the direction of the Cancer Center's research Programs and support services. Section 7.1 describes the key appointments, credentials, and responsibilities of the Executive Director and each Cabinet member, which are critical to achieve the strategic goals of HCI as an NCI-Designated Cancer Center. Though not directly involved in leading the CCSG efforts, the Senior Director of Clinical Affairs and HCH Executive Director support the goals of the CCSG by overseeing clinical operations and planning as well as facilitating integration of HCI's research and clinical care missions.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Salt Lake City
United States
Zip Code
Albright, Frederick; Stephenson, Robert A; Agarwal, Neeraj et al. (2015) Prostate cancer risk prediction based on complete prostate cancer family history. Prostate 75:390-8
Eiring, A M; Page, B D G; Kraft, I L et al. (2015) Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. Leukemia 29:586-97
Lerman, Daniel M; Monument, Michael J; McIlvaine, Elizabeth et al. (2015) Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 62:759-65
Quackenbush, John F; Cassidy, Pamela B; Pfeffer, Lawrence M et al. (2014) Isolation of circulating microRNAs from microvesicles found in human plasma. Methods Mol Biol 1102:641-53
Clark, Kathleen A; Graves, Barbara J (2014) Dual views of SRF: a genomic exposure. Genes Dev 28:926-8
Oakley, Gretchen M; Curtin, Karen; Layfield, Lester et al. (2014) Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg 140:423-7
Zhang, Rui; Yang, Jiyuan; Sima, Monika et al. (2014) Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates. Proc Natl Acad Sci U S A 111:12181-6
Smith, M A; Hoffman, L M; Beckerle, M C (2014) LIM proteins in actin cytoskeleton mechanoresponse. Trends Cell Biol 24:575-83
Van Vranken, Jonathan G; Bricker, Daniel K; Dephoure, Noah et al. (2014) SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration. Cell Metab 20:241-52
Gibson, Summer B; Figueroa, Karla P; Bromberg, Mark B et al. (2014) Familial clustering of ALS in a population-based resource. Neurology 82:17-22

Showing the most recent 10 out of 805 publications